Recipharm and binx health announced that they have signed a long-term manufacturing agreement for the supply of single use cartridges for the binx io platform with supply of single use cartridges commencing immediately. The agreement is the culmination of the partnership between binx health and Recipharm spanning many years and facilitates the bringing to market of what is expected to be a transformational diagnostics platform, providing almost instantaneous results to both patients and clinicians for the diagnosis of chlamydia and gonorrhoea. Recipharm will supply cartridges from the Kings Lynn operation in the United Kingdom.